Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit

Respiratory Medicine

Volumn 109, Issue 6, 2015, Pages 743-750

  Cavallazzi, Rodrigo ^a   Wiemken, Timothy ^a   Arnold, Forest W ^a   Luna, Carlos M ^b   Bordon, Jose ^c   Kelley, Robert ^a   Feldman, Charles ^d   Chalmers, James D ^e   Torres, Antoni ^f   Ramirez, Julio ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Providence Hospital Washington DC   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cohort; Epidemiology; Infection; Outcomes; Pneumonia; Sepsis

Indexed keywords

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY ANALYSIS; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; KAPLAN MEIER METHOD; MULTICENTER STUDY; PNEUMONIA; PROGNOSIS; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; REGRESSION ANALYSIS;

EID: 84937191868     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.04.007     Document Type: Article

References (39)

1. H. Yu, J. Rubin, S. Dunning, S. Li, and R. Sato Clinical and economic burden of community-acquired pneumonia in the medicare fee-for-service population J Am Geriatrics Soc 60 11 2012 2137 2143
2. H. Georges, C. Journaux, and P. Devos Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia BMC Infect Dis 13 2013 196-2334-13-196
3. A. Khawaja, A.B. Zubairi, F.K. Durrani, and A. Zafar Etiology and outcome of severe community acquired pneumonia in immunocompetent adults BMC Infect Dis 13 2013 94-2334-13-94
4. J. Rello, A. Rodriguez, T. Lisboa, M. Gallego, M. Lujan, and R. Wunderink PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia Crit Care Med 37 2 2009 456 462
5. S. Aliberti, A. Amir, and P. Peyrani Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia Chest 134 5 2008 955 962
6. R.P. Dellinger, J.M. Carlet, and H. Masur Surviving sepsis campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 3 2004 858 873
7. R.P. Dellinger, M.M. Levy, and J.M. Carlet Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 1 2008 296 327
8. R.P. Dellinger, M.M. Levy, and A. Rhodes Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Crit Care Med 41 2 2013 580 637
9. L.A. Mandell, R.G. Wunderink, and A. Anzueto Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis: official Publ Infect Dis Soc Am 44 Suppl 2 2007 S27 S72
10. H.S. Sader, T.R. Fritsche, K. Kaniga, Y. Ge, and R.N. Jones Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains Antimicrob Agents Chemother 49 8 2005 3501 3512
11. D.L. Stevens, D. Herr, H. Lampiris, J.L. Hunt, D.H. Batts, and B. Hafkin Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections Clin Infect Dis: official Publ Infect Dis Soc Am 34 11 2002 1481 1490
12. P.M. Houck, D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia Archives Intern Med 164 6 2004 637 644
13. J. Mahony, S. Chong, and F. Merante Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay J Clin Microbiol 45 9 2007 2965 2970
14. R. Daniels, T. Nutbeam, G. McNamara, and C. Galvin The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study Emerg Med J: EMJ 28 6 2011 507 512
15. R. Ferrer, A. Artigas, and M.M. Levy Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain JAMA: J Am Med Assoc 299 19 2008 2294 2303
16. M.M. Levy, R.P. Dellinger, and S.R. Townsend The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis Intensive care Med 36 2 2010 222 231
17. S. Na, W.S. Kuan, and M. Mahadevan Implementation of early goal-directed therapy and the surviving sepsis campaign resuscitation bundle in Asia Int J Qual health care: J Int Soc Qual Health Care/ISQua 24 5 2012 452 462
18. H.B. Nguyen, S.W. Corbett, and R. Steele Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality Crit Care Med 35 4 2007 1105 1112
19. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 10 2001 699 709
20. F.M. Brunkhorst, C. Engel, and F. Bloos Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 2 2008 125 139
21. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 19 2001 1368 1377
22. J.A. Ramirez Fostering international multicenter collaborative research: the CAPO Project Int J Tuberc lung Dis: official J Int Union against Tuberc Lung Dis 11 10 2007 1062 1065
23. M.J. Fine, T.E. Auble, and D.M. Yealy A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 4 1997 243 250
24. A.M. Fry, D.K. Shay, R.C. Holman, A.T. Curns, and L.J. Anderson Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002 JAMA: J Am Med Assoc 294 21 2005 2712 2719
25. R.A. Stein Lessons from outbreaks of H1N1 influenza Ann Intern Med 151 1 2009 59 62
26. J.S. Francis, M.C. Doherty, and U. Lopatin Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the panton-valentine leukocidin genes Clin Infect Dis: official Publ Infect Dis Soc Am 40 1 2005 100 107
27. D.R. Pillai, D. Shahinas, and A. Buzina Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae BMC genomics 10 2009 642-2164-10-642
28. S.R. Palumbi Humans as the world's greatest evolutionary force Science 293 5536 2001 1786 1790 (New York, N.Y.)
29. P.P. Gleason, W.N. Kapoor, and R.A. Stone Medical outcomes and antimicrobial costs with the use of the American thoracic society guidelines for outpatients with community-acquired pneumonia JAMA: J Am Med Assoc 278 1 1997 32 39
30. N.C. Dean, K.A. Bateman, S.M. Donnelly, M.P. Silver, G.L. Snow, and D. Hale Improved clinical outcomes with utilization of a community-acquired pneumonia guideline Chest 130 3 2006 794 799
31. J.A. Ramirez Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet? Eur Respir J 41 1 2013 5 6
32. M.F. Engel, D.F. Postma, and M.E. Hulscher Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Eur Respir J 41 1 2013 123 130
33. D.M. Rubio, E.E. Schoenbaum, and L.S. Lee Defining translational research: implications for training Acad Med: J Assoc Am Med Coll 85 3 2010 470 475
34. S.H. Woolf The meaning of translational research and why it matters JAMA: J Am Med Assoc 299 2 2008 211 213
35. M. Woodhead, C.A. Welch, D.A. Harrison, G. Bellingan, and J.G. Ayres Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC case mix programme Database Crit Care 10 Suppl 2 2006 S1 (London, England)
36. G.W. Ruhnke, M. Coca-Perraillon, B.T. Kitch, and D.M. Cutler Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia Am J Med 124 2 2011 171 178 e1
37. S. Gattarello, B. Borgatta, and J. Sole-Violan Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013) Chest 146 1 2014 Jul 1 22 31
38. M. Ruiz, S. Ewig, and A. Torres Severe community-acquired pneumonia. Risk factors and follow-up epidemiology Am J Respir Crit care Med 160 3 1999 923 929
39. A. Torres, J. Serra-Batlles, and A. Ferrer Severe community-acquired pneumonia. Epidemiology and prognostic factors Am Rev Respir Dis 144 2 1991 312 318